Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors

By F. Din, W. Aman, Izhar Ullah, O. S. Qureshi, O. Mustapha, S. Shafique, Alam Zeb. International Journal of Nanomedicine, 2017

1,044 citations recorded by the source corpus.

Nanotechnology has recently gained increased attention for its capability to effectively diagnose and treat various tumors. Nanocarriers have been used to circumvent the problems associated with conventional antitumor drug delivery systems, including their nonspecificity, severe side effects, burst release and damaging the normal cells. Nanocarriers improve the bioavailability and therapeutic efficiency of antitumor drugs, while providing preferential accumulation at the target site. A number of nanocarriers have been developed; however, only a few of them are clinically approved for the delivery of antitumor drugs for their intended actions at the targeted sites. The present review is divided into three main parts: first part presents introduction of various nanocarriers and their relevance in the delivery of anticancer drugs, second part encompasses targeting mechanisms and surface functionalization on nanocarriers and third part covers the description of selected tumors, including breast, lungs, colorectal and pancreatic tumors, and applications of relative nanocarriers in these tumors. This review increases the understanding of tumor treatment with the promising use of nanotechnology.

Subfields: Biomaterials, Biomedical Engineering, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/c5b4b1afd80c741dadabedcd64aa1e6a63349b1e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. M. T. Caccamo
  2. M. Kiselev
  3. D. Lombardo
  4. R. Love
  5. Naghmeh Abbasi
  6. S. Hamlet
  7. Nam-Trung Nguyen

Citations in the corpus